Bbva Compass Bancshares Inc. lowered its stake in Cooper Companies, Inc. (The) (NYSE:COO) by 8.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,789 shares of the medical device company’s stock after selling 174 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Cooper Companies, Inc. (The) were worth $428,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. raised its stake in Cooper Companies, Inc. (The) by 5.4% in the first quarter. Vanguard Group Inc. now owns 4,781,732 shares of the medical device company’s stock valued at $955,821,000 after buying an additional 244,531 shares in the last quarter. BlackRock Inc. raised its stake in Cooper Companies, Inc. (The) by 2,849.1% in the first quarter. BlackRock Inc. now owns 3,071,637 shares of the medical device company’s stock valued at $613,991,000 after buying an additional 2,967,481 shares in the last quarter. Janus Capital Management LLC raised its stake in Cooper Companies, Inc. (The) by 35.7% in the first quarter. Janus Capital Management LLC now owns 1,743,182 shares of the medical device company’s stock valued at $348,441,000 after buying an additional 458,173 shares in the last quarter. Champlain Investment Partners LLC raised its stake in Cooper Companies, Inc. (The) by 6.6% in the first quarter. Champlain Investment Partners LLC now owns 524,375 shares of the medical device company’s stock valued at $104,817,000 after buying an additional 32,270 shares in the last quarter. Finally, Pioneer Investment Management Inc. raised its stake in Cooper Companies, Inc. (The) by 59.2% in the first quarter. Pioneer Investment Management Inc. now owns 518,222 shares of the medical device company’s stock valued at $103,588,000 after buying an additional 192,723 shares in the last quarter. Institutional investors and hedge funds own 99.97% of the company’s stock.

Shares of Cooper Companies, Inc. (NYSE COO) opened at 244.63 on Tuesday. The firm has a 50-day moving average of $244.79 and a 200-day moving average of $212.04. The firm has a market cap of $11.95 billion, a price-to-earnings ratio of 36.68 and a beta of 0.61. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39.

Cooper Companies, Inc. (The) (NYSE:COO) last issued its quarterly earnings results on Thursday, June 1st. The medical device company reported $2.50 EPS for the quarter, topping the Zacks’ consensus estimate of $2.25 by $0.25. The firm had revenue of $522.40 million for the quarter, compared to analyst estimates of $520.71 million. Cooper Companies, Inc. (The) had a net margin of 16.02% and a return on equity of 15.88%. The business’s revenue for the quarter was up 8.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.05 EPS. On average, analysts anticipate that Cooper Companies, Inc. will post $9.63 EPS for the current year.

The business also recently declared a semiannual dividend, which was paid on Monday, August 7th. Stockholders of record on Friday, July 21st were issued a $0.03 dividend. This represents a dividend yield of 0.02%. The ex-dividend date of this dividend was Wednesday, July 19th. Cooper Companies, Inc. (The)’s payout ratio is 0.90%.

ILLEGAL ACTIVITY WARNING: “Bbva Compass Bancshares Inc. Has $428,000 Stake in Cooper Companies, Inc. (The) (NYSE:COO)” was originally reported by Daily Political and is the sole property of of Daily Political. If you are viewing this piece on another site, it was copied illegally and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at https://www.dailypolitical.com/2017/08/08/bbva-compass-bancshares-inc-has-428000-stake-in-cooper-companies-inc-the-nysecoo.html.

COO has been the topic of several analyst reports. J P Morgan Chase & Co reiterated a “neutral” rating and set a $206.00 price target (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Jefferies Group LLC restated a “buy” rating and issued a $250.00 target price (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Zacks Investment Research upgraded shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $243.00 target price on the stock in a research report on Tuesday, May 23rd. BMO Capital Markets restated a “buy” rating and issued a $255.00 target price on shares of Cooper Companies, Inc. (The) in a research report on Thursday, July 13th. Finally, Oppenheimer Holdings, Inc. set a $225.00 target price on shares of Cooper Companies, Inc. (The) and gave the company a “hold” rating in a research report on Saturday, June 3rd. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Cooper Companies, Inc. (The) currently has a consensus rating of “Buy” and a consensus target price of $242.00.

In other news, CEO Paul L. Remmell sold 9,294 shares of the company’s stock in a transaction on Friday, July 14th. The shares were sold at an average price of $248.46, for a total value of $2,309,187.24. Following the completion of the sale, the chief executive officer now owns 6,186 shares of the company’s stock, valued at approximately $1,536,973.56. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Stanley Md Zinberg sold 816 shares of the company’s stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $243.14, for a total transaction of $198,402.24. The disclosure for this sale can be found here. Insiders sold a total of 67,331 shares of company stock worth $16,400,454 in the last three months. Insiders own 1.60% of the company’s stock.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies, Inc. (The) (NYSE:COO).

Institutional Ownership by Quarter for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.